PUBLISHER: Grand View Research | PRODUCT CODE: 1511970
PUBLISHER: Grand View Research | PRODUCT CODE: 1511970
The U.S. PTA balloon catheter market size is anticipated to reach USD 2.02 billion by 2030 and is anticipated to expand at a CAGR of 9.61% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several key factors, including the rising incidence of cardiovascular diseases and peripheral artery disease, the increasing popularity of minimally invasive procedures, and the geriatric population. According to the Population Reference Bureau, there will be a significant rise in the number of Americans aged 65 or above from 58 million in 2022 to 82 million by 2050. This indicates a 47% surge in the elderly population, accounting for a higher proportion of the overall population, rising from 17% to 23%.
The healthcare industry has been witnessing a significant increase in minimally invasive procedures. Medical professionals and patients are opting more for minimally invasive procedures such as percutaneous transluminal angioplasty (PTA) using balloon catheters. Such procedures have various benefits over traditional open surgeries, including faster recovery times, reduced discomfort, and lower risks of complications.
Technological advancements have been vital in driving innovation in PTA balloon catheters. The manufacturers continuously develop new catheter designs, materials, coatings, and delivery systems to improve performance, safety, and patient outcomes. Moreover, incorporating technologies such as drug-coated balloons and digital imaging significantly improved the effectiveness of PTA procedures.